Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN
Robert A. O'Reilly, … , Paul M. Aggeler, Lois S. Leong
Robert A. O'Reilly, … , Paul M. Aggeler, Lois S. Leong
Published October 1, 1963
Citation Information: J Clin Invest. 1963;42(10):1542-1551. https://doi.org/10.1172/JCI104839.
View: Text | PDF
Research Article Article has an altmetric score of 7

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN

  • Text
  • PDF
Abstract

Authors

Robert A. O'Reilly, Paul M. Aggeler, Lois S. Leong

×

Total citations by year

Year: 2024 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2007 2006 2005 2004 2002 2001 1998 1997 1996 1994 1993 1992 1991 1989 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1967 1966 1965 1964 Total
Citations: 1 1 3 4 1 9 1 1 4 3 3 5 4 2 2 2 6 1 1 2 1 1 1 3 1 1 2 1 2 5 5 2 4 3 3 1 2 3 7 4 6 6 4 4 2 3 4 6 4 3 1 2 153
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (153)

Title and authors Publication Year
A fully automatic tool for development of population pharmacokinetic models
Chen X, Nordgren R, Belin S, Hamdan A, Wang S, Yang T, Huang Z, Carter SJ, Buatois S, Abrantes JA, Hooker AC, Karlsson MO
CPT: Pharmacometrics & Systems Pharmacology 2024
Antithrombotic and Antiplatelet Drug Toxicity
DB Liss, ME Mullins
Critical Care Clinics 2021
A Primary Amide-Functionalized Heterogeneous Catalyst for the Synthesis of Coumarin-3-carboxylic Acids via a Tandem Reaction
D Markad, S Khullar, SK Mandal
Inorganic Chemistry 2020
Environmental Toxicants: Human Exposures and Their Health Effects
M Lippmann, GD Leikauf
2020
In silico, 6LU7 protein inhibition using dihydroxy-3-phenyl coumarin derivatives for SARS-CoV-2
M ÖZDEMİR, B KÖKSOY, D CEYHAN, M BULUT, B YALCİN
2020
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
I Rubinstein, R van Breemen, DG Nosal, G Weinberg, RC Hershow, DL Feinstein
Drugs in R & D 2019
Photoinduced cyclization of alkynoates to coumarins with N-Iodosuccinimide as a free-radical initiator under ambient and metal-free conditions
Z Wang, X Li, L Wang, P Li
Tetrahedron 2019
Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand
S Hennig, JA Hannam, CM Kirkpatrick, CE Staatz, S Holford, SB Duffull, HS AlSallami, BG Charles, N Holford, DJ Foster
CPT Pharmacometrics Syst. Pharmacol. 2019
Study on Anti-Tumor Activity of Novel 3-Substituted 4 Anilino-Coumarin Derivatives Using Quantitative Structure-Activity Relationship (QSAR)
DE Putri, HD Pranowo, W Haryadi
Materials Science Forum 2019
Pd-catalysed carbonylative annulation of salicylaldehydes with benzyl chlorides using N -formylsaccharin as a CO surrogate
VK Yadav, VP Srivastava, LD Yadav
New Journal of Chemistry 2018
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide
A la Peña, X Cui, J Geiser, C Loghin
Clinical Pharmacokinetics 2017
PharmML in Action: an Interoperable Language for Modeling and Simulation: PharmML in Action
R Bizzotto, E Comets, G Smith, F Yvon, NR Kristensen, MJ Swat
CPT Pharmacometrics Syst. Pharmacol. 2017
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics: Evaluation Graphs for Population PK/PD Models
TH Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, AC Hooker, J John, MO Karlsson, DR Mould, JJ Ruixo, EL Plan, R Savic, JG van Hasselt, B Weber, C Zhou, E Comets, F Mentré
CPT Pharmacometrics Syst. Pharmacol. 2017
Assessing robustness of designs for random effects parameters for nonlinear mixed-effects models
SB Duffull, AC Hooker
Journal of Pharmacokinetics and Pharmacodynamics 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
QX Ooi, DF Wright, RC Tait, GK Isbister, SB Duffull
Clinical Pharmacokinetics 2017
Anticoagulant Rodenticides and Wildlife
NW van Brink, JE Elliott, RF Shore, BA Rattner
2017
The Long-Lasting Rodenticide Brodifacoum Induces Neuropathology in Adult Male Rats
S Kalinin, N Marangoni, K Kowal, A Dey, K Lis, S Brodsky, R van Breemen, Z Hauck, R Ripper, I Rubinstein, G Weinberg, DL Feinstein
Toxicological Sciences 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
, DF Wright, RC Tait, GK Isbister, SB Duffull
Clinical Pharmacokinetics 2017
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide
A de la Peña, X Cui, J Geiser, C Loghin
Clinical Pharmacokinetics 2017
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures: The emerging threat of superwarfarins
DL Feinstein, BS Akpa, MA Ayee, AI Boullerne, D Braun, SV Brodsky, D Gidalevitz, Z Hauck, S Kalinin, K Kowal, I Kuzmenko, K Lis, N Marangoni, MW Martynowycz, I Rubinstein, R Breemen, K Ware, G Weinberg
Annals of the New York Academy of Sciences 2016
Electroreductive Dimerization of Coumarin and Coumarin Analogues at Carbon Cathodes
EM Pasciak, JT Rittichier, CH Chen, MS Mubarak, MS VanNieuwenhze, DG Peters
The Journal of Organic Chemistry 2015
Toxin-induced Coagulopathy
P Chai, K Babu
Emergency Medicine Clinics of North America 2014
Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies: Software for designs in pharmacometrics
J Nyberg, C Bazzoli, K Ogungbenro, A Aliev, S Leonov, S Duffull, AC Hooker, F Mentré
British Journal of Clinical Pharmacology 2014
Is personalized medicine a dream or a reality?
BL Morse, RB Kim
Critical Reviews in Clinical Laboratory Sciences 2014
Reduction of Substituted Phenyl 2-Chloroacetates at Silver Cathodes: Electrosynthesis of Coumarins
EM Pasciak, DG Peters
Journal of The Electrochemical Society 2014
How Warfarin’s Structural Diversity Influences Its Phospholipid Bilayer Membrane Permeation
BC Karlsson, GD Olsson, R Friedman, AM Rosengren, H Henschel, IA Nicholls
The Journal of Physical Chemistry B 2013
Study of structure–activity relationship of enantiomeric, protonated and deprotonated forms of warfarin via vibrational spectroscopy and DFT calculations
A Mishra, SK Srivastava, D Swati
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2013
The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace
M Nasterlack
The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace 2013
Biotransformation (Metabolism) of Pesticides
E Hodgson
Pesticide Biotransformation and Disposition 2012
Synthesis of Coumarins via Pd-Catalyzed Oxidative Cyclocarbonylation of 2-Vinylphenols
J Ferguson, F Zeng, H Alper
Organic letters 2012
Standardized Visual Predictive Check Versus Visual Predictive Check for Model Evaluation
DD Wang, S Zhang
The Journal of Clinical Pharmacology 2012
Development of a Bayesian Forecasting Method for Warfarin Dose Individualisation
DF Wright, SB Duffull
Pharmaceutical Research 2011
Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure
A Lee, M Crowther
Journal of Thrombosis and Thrombolysis 2011
Understanding the time course of pharmacological effect: a PKPD approach
DF Wright, HR Winter, SB Duffull
British Journal of Clinical Pharmacology 2011
NovelCYP2C9andVKORC1gene variants associated with warfarin dosage variability in the South African black population
C Mitchell, N Gregersen, A Krause
Pharmacogenomics 2011
Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation
IY Gong, UI Schwarz, N Crown, GK Dresser, A Lazo-Langner, GY Zou, DM Roden, CM Stein, M Rodger, PS Wells, RB Kim, RG Tirona, UM Zanger
PloS one 2011
Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics–Pharmacodynamics
RM Savic, F Mentré, M Lavielle
The AAPS Journal 2010
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0
C Bazzoli, S Retout, F Mentré
Computer Methods and Programs in Biomedicine 2010
Hayes' Handbook of Pesticide Toxicology
M Lotti
Hayes' Handbook of Pesticide Toxicology 2010
Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report
G Giunta
Case Reports in Medicine 2010
Effect of gefitinib on warfarin antithrombotic activity
S Arai, H Mitsufuji, Y Nishii, S Onoda, S Ryuge, M Wada, K Katono, M Iwasaki, A Takakura, S Otani, M Yamamoto, T Yanaihara, M Yokoba, M Kubota, M Katagiri, T Fukui, H Kobayashi, N Yanase, R Hataishi, N Masuda
International Journal of Clinical Oncology 2009
Malabsorption-associated warfarin resistance
BJ Sabol, RR Basa, CE Wilkins
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2009
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium
S Ghosh, UR Pendurthi, A Steinoe, CT Esmon, LV Rao
The Journal of biological chemistry 2007
Glucuronidation of Monohydroxylated Warfarin Metabolites by Human Liver Microsomes and Human Recombinant UDP-Glucuronosyltransferases
A Zielinska, CF Lichti, S Bratton, NC Mitchell, A Gallus-Zawada, , M Finel, GP Miller, A Radominska-Pandya, JH Moran
The Journal of pharmacology and experimental therapeutics 2007
Pharmacodynamic Model for Warfarin under Thrombo-test Monitoring
S Sato, F Hongo, N Hanawa, M Hirokami, K Matsuda, Y Minemawari, M Takigahira, T Toda, N Kurosawa, E Owada
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2006
Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists
A Blesius, S Chabaud, M Cucherat, P Mismetti, JP Boissel, P Nony
Clinical Pharmacokinetics 2006
Factor VIIa binding and internalization in hepatocytes
G Hjortoe, BB Sorensen, LC Petersen, LV Rao
Journal of Thrombosis and Haemostasis 2005
Anticoagulant Rodenticides
BE Watt, AT Proudfoot, SM Bradberry, JA Vale
Toxicological Reviews 2005
Comparative Pharmacokinetics of Vitamin K Antagonists
M Ufer
Clinical Pharmacokinetics 2005
Rodenticides
L Gamelin, P Harry
EMC - Toxicologie-Pathologie 2005
Significant Effect of Capecitabine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Cancer
R Camidge, B Reigner, J Cassidy, S Grange, M Abt, E Weidekamm, D Jodrell
Journal of Clinical Oncology 2005
Comparative Pharmacokinetics of Vitamin K Antagonists: Warfarin, Phenprocoumon and Acenocoumarol
M Ufer
Clinical Pharmacokinetics 2005
Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism
M McGuire, PP Dobesh
Journal of Pharmacy Practice 2004
Assessment of risks of brodifacoum to non-target birds and mammals in New Zealand
Charles T Eason, Elaine C Murphy, Geoffrey R G Wright, Eric B Spurr
Ecotoxicology 2002
Handbook of Pesticide Toxicology
RM Hollingworth
Handbook of Pesticide Toxicology 2001
Antithrombotic Therapy for Venous Thromboembolic Disease
TM Hyers, G Agnelli, RD Hull, TA Morris, M Samama, V Tapson, JG Weg
Chest 2001
Oral Anticoagulants
J Hirsh, JE Dalen, DR Anderson, L Poller, H Bussey, J Ansell, D Deykin, JT Brandt
Chest 1998
Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation
M Kuranari, M Hara, T Saikawa, Y Kodama, H Matsuo, T Sakata, M Takeyama
Journal of Clinical Pharmacy and Therapeutics 1997
Warfarin Withdrawal: Pharmacokinetic-Pharmacodynamic Considerations
G Palareti, C Legnani
Clinical Pharmacokinetics 1996
Capillary electrophoretic separation of anticoagulant rodenticides in aqueous electrolytes modified with organic solvents
C Stathakis, PL Warburton, RM Cassidy
Journal of Chromatography A 1994
Hagers Handbuch der Pharmazeutischen Praxis
M Albinus, G Amschler, U Amschler, E von Angerer, W Barthel, A Bauer, K Bauer, J Beckmann, W Beil, J Beitz, P Berscht, T Beyrich, K Binder, R Böhme, HH Borchert, F Bracher, H Bräunlich, K Brinkmann, F von Bruchhausen, K Brune, A Büge, W Christ, M Cimbollek, R Daniels, G Dannhardt, HJ Duchstein, S Ebel, K Eger, P Emig, T Erker, MS Fernandez-Alfonso, AW Frahm, M Frahm, KJ Freundt, D Geffken, U Geis, E Glusa, B Göber, J Gödicke, M Goppelt-Strübe, W Gössling, A Graul, S Greiner, A Grisk, M Grosam, M von Gruchalla, M Gütschow, A Haberkorn, E Hackenthal, A Häfner, B Haluszczynski, A Harder, S Hartmann, S Hartmann, D Heber, G Heinemeyer, A Hensel, S Hoedt-Schmidt, H Hoffmann, U Hoffmann-Schollmayer, U Holzgrabe, M Hug, W Ibrom, E Inkmann, J Jürgens, B Kaiser, DA Kalbhen, N Khudeir, W Kiefer, D Kleinsorge, C Klett, S Klett, M Klingmüller, HP Klöcking, G Kobal, A Kramer, M Kreher, G Kreutz, R Kroker, D Landsiedel-Maier, J Lehmann, MS Lehner, S Leiner, H Löwe, J Mann, D Manns, W Matthiessen, A Maurer, W Meindl, K Menges, P Messinger, HJ Mest, FP Meyer, J Mollière, R Morgenstern, W Morick, J Mössner, C Müller, D Müller, K Müller, W Müller, A Mülsch, T Netzer, M Neugebauer, U Niemeyer, P Nuhn, B Nürnberg, J Oertel, M Oettel, H Oßwald, R Ott, T Ott, T Otzen, P Pachaly, H Pelzer, KU Petersen, M Pickert, A Pies, K Pietrzik, D Preiss, H Priewer, O Queckenberg, E Reimann, J Remien, R Rettig, A Reymann, J Richter, H Rommelspacher, U Rose, G Rücker, K Schaefer, H Schlager, W Schleicher, H Schleinitz, W Schlichter, H Schmidhammer, G Schmidt, T Schmidt, J Schräder, T Schulz, G Schulze, P Schwanz, H Schwilden, M Serke, G Skopp, M Spohn, R Stahlmann, JP Stasch, C Steffen, J Steinmeyer, KH Surborg, U Sürig, I Szelenyi, R Troschütz, M Verborg, EJ Verspohl, FJ Volk, H Walther, H Weber, J Wede, M Wenzel, M Weyandt-Spangenberg, S Wich, H Winterhoff, R Wintersteiger, F Woltmann, D Youssef, A Ziegler
1994
Clinically Significant Drug Interactions with the Oral Anticoagulants:
MD Freedman, AG Olatidoye
Drug Safety 1994
Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
A Yacobi, JP Skelly, VP Shah, LZ Benet
1993
Oral Anticoagulants: Pharmacodynamics, Clinical Indications and Adverse Effects
MD Freedman
The Journal of Clinical Pharmacology 1992
Classes of Pesticides
AF Pelfrene
Classes of Pesticides 1991
Decreased Hypoprothrombinemic Response to Warfarin Secondary to the Warfarin-Nafcillin Interaction
VA Shovick, TL Rihn
1991
Clinical Pharmacokinetic Considerations in the Control of Oral Anticoagulant Therapy:
HG Shetty, AG Fennerty, PA Routledge
Clinical Pharmacokinetics 1989
The anticoagulant activity of some selected warfarin analogues
AO Obaseki, HB Coker
Journal of Pharmacy and Pharmacology 1987
ASPECTS OF ANTICOAGULANT ACTION: A Review of the Pharmacology, Metabolism and Toxicology of Warfarin and Congeners
FA Sutcliff, AD MacNicoll, GG Gibson
Drug Metabolism and Drug Interactions 1987
Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins
BK Park, IA Choonara, BP Haynes, AM Breckenridge, RG Malia, FE Preston
British Journal of Clinical Pharmacology 1986
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer
PE Lnning, PM Ueland, S Kvinnsland
Cancer Chemotherapy and Pharmacology 1986
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
E Jucker
1986
Reversed-phase high-performance liquid chromatographic method for the determination of warfarin from biological fluids in the low nanogram range
JM Steyn, HM Merwe, MJ Kock
Journal of Chromatography B: Biomedical Sciences and Applications 1986
Clinical Pharmacokinetics and Pharmacodynamics of Warfarin: Understanding the Dose-Effect Relationship
NH Holford
Clinical Pharmacokinetics 1986
A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit
AM Breckenridge, S Cholerton, JA Hart, BK Park, AK Scott
British Journal of Pharmacology 1985
Progress in Medicinal Chemistry
JR Brown, SH Imam
Progress in Medicinal Chemistry 1985
High-performance liquid chromatographic strategies for the determination and confirmation of anticoagulant rodenticide in animal tissues
K Hunter
Journal of Chromatography A 1985
Drugs in the Management of Heart Disease
A Breckenridge
1985
Uses of heparin and warfarin
JV Lloyd
The Medical Journal of Australia 1985
Coagulation recovery after warfarin-induced hypoprothrombinaemia by oral administration of liposomally-associated vitamin K1 to rabbits
M Nagata, T Yotsuyanagi, M Nonomura, K Ikeda
Journal of Pharmacy and Pharmacology 1984
Antithrombotic Therapy for Venous Thromboembolism
TM Hyers
Clinics in Chest Medicine 1984
Acenocoumarol and its amino and acetamido metabolites. Comparative pharmacokinetics and pharmacodynamics in the rat
HH Thijssen, LG Baars, MJ Reijnders
Journal of Pharmacy and Pharmacology 1983
Warfarin: a review with emphasis on its use in the horse
A Vrins, G Carlson, B Feldman
The Canadian veterinary journal. La revue vétérinaire canadienne 1983
Dose-Dependent Pharmacokinetics: Emphasis on Phase I Metabolism
PG Dayton, JE Sanders
Drug Metabolism Reviews 1983
Drug Interactions with Warfarin:
MJ Serlin, AM Breckenridge
Drugs 1983
Fixation plasmatique et pharmacocinétique des médicaments
JP Tillement, R Zini, S Glasson, B Jacotot
La Revue de Médecine Interne 1982
Inhibition by coumadin anticoagulants of enzymatic outer ring monodeiodination of iodothyronines
A Goswami, JL Leonard, IN Rosenberg
Biochemical and Biophysical Research Communications 1982
Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man
RA O'Reilly
Circulation 1982
Pharmacokinetics of warfarin in rabbits during short-term and long-term uraemia
E Tvedegaard, J Ladefoged, O Ladefoged
Journal of Veterinary Pharmacology and Therapeutics 1981
Laser-induced photoacoustic detector for high-performance liquid chromatography
S Oda, T Sawada
Analytical Chemistry 1981
High-performance liquid chromatography separation and fluorescence detection of warfarin and its metabolites by postcolumn acid/base manipulation
SH Lee, LR Field, WN Howald, WF Trager
Analytical Chemistry 1981
Influence of dietary protein on the response of rats receiving toxic levels of warfarin
DL Barber, HW Colvin
Toxicology and Applied Pharmacology 1980
A preliminary report on the use of Warfarin in the Treatment of Navicular Disease
CM Colles
Equine Veterinary Journal 1979
Clinical Pharmacokinetics of Oral Anticoagulants:
JG Kelly, K OʼMalley
Clinical Pharmacokinetics 1979
Treatment and protherombin responses during warfarin toxicosis in rats and mice
L Penumarthy, FW Oehme
Toxicology 1978
Comparison of high-performance liquid chromatography and a spectrophotometric technique for determining plasma warfarin
WB Forman, J Shlaes
Journal of Chromatography B: Biomedical Sciences and Applications 1978
The Effect of Furosemide and Bumetanide on Warfarin Metabolism and Anticoagulant Response
CM Nilsson, ES Horton, DS Robinson
The Journal of Clinical Pharmacology 1978
Drug administration in renal failure
JS Cheigh
The American Journal of Medicine 1977
Warfarin Elimination and Responsiveness in Patients with Renal Dysfunction
K Bachmann, R Shapiro, J Mackiewicz
The Journal of Clinical Pharmacology 1977
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma
OG Nilsen, L Storstein, S Jacobsen
Biochemical Pharmacology 1977
Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model
M Kekki, RJ Julkunen, B Wahlstrm
Naunyn-Schmiedeberg's Archives of Pharmacology 1977
Interindividual Differences in the Response to Oral Anticoagulants:
AM Breckenridge
Drugs 1977
Plasma Protein Binding of Phenytoin and Warfarin in Patients Undergoing Renal Transplantation1:
I Odar-Cederlof
Clinical Pharmacokinetics 1977
Protein Binding of Coumarin Anticoagulants in Disease States:
K Bachmann, R Shapiro
Clinical Pharmacokinetics 1977
GLC determination of plasma concentrations of phenprocoumon
KK Midha, JW Hubbard, JK Cooper, IJ McGilveray
Journal of Pharmaceutical Sciences 1976
Multimodal distribution of warfarin binding to protein in serum of male-sprague dawley rats
JT Slattery, A Yacobi, G Levy
Life Sciences 1976
The Stereoselective Interaction of Warfarin and Metronidazole in Man
RA O'Reilly
New England Journal of Medicine 1976
Pharmacodynamic and Pharmacokinetic Drug Interactions with Coumarin Anticoagulants:
SM MacLeod, EM Sellers
Drugs 1976
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references
LA Pagliaro, LZ Benet
Journal of Pharmacokinetics and Biopharmaceutics 1975
Comparative pharmacokinetics of coumarin anticoagulants XIV: Relationship between protein binding, distribution, and elimination kinetics of warfarin in rats
A Yacobi, G Levy
Journal of Pharmaceutical Sciences 1975
Continued anticoagulation in oral surgery procedures
SM Roser, B Rosenbloom
Oral Surgery, Oral Medicine, Oral Pathology 1975
Drug Design
HJ Herms, V Taenzer
Drug Design 1975
Anticoagulant effect and plasma kinetics of fluorophenindione after a single dose in man
, JJ Thbault, C Mattei, P d'Athis, C Blatrix
European Journal of Clinical Pharmacology 1975
A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man
G Houin, JJ Thbault, P d'Athis, ,
European Journal of Clinical Pharmacology 1975
Toxic effects of warfarin in rats fed different diets
HW Colvin, WL Wang
Toxicology and Applied Pharmacology 1974
Comparative pharmacokinetics of coumarin anticoagulants X: Relationship between distribution, elimination, and anticoagulant action of warfarin
A Yacobi, LB Wingard, G Levy
Journal of Pharmaceutical Sciences 1974
Effect of plasma protein binding on elimination of warfarin
G Levy, A Yacobi
Journal of Pharmaceutical Sciences 1974
GLC determination of warfarin in human plasma
DG Kaiser, RS Martin
Journal of Pharmaceutical Sciences 1974
GLC determination of plasma levels of warfarin
KK Midha, IJ McGilveray, JK Cooper
Journal of Pharmaceutical Sciences 1974
Blood
WH Crosby
Blood 1974
Multiple-dose kinetics of oral anticoagulants: Methods of analysis and optimized dosing
TG Theofanous, RG Barile
Journal of Pharmaceutical Sciences 1973
Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man*
DS Hewick, J Mcewen
Journal of Pharmacy and Pharmacology 1973
Neunundsiebzigster Kongress
K Miehlke
1973
Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man
C Harvengt, JP Desager
European Journal of Clinical Pharmacology 1973
Multiple-dose kinetics of pharmacological effects of indirect anticoagulants
TG Theofanous, VF Smolen
Journal of Pharmaceutical Sciences 1972
Vitamin K and warfarin
IL Woolf, BM Babior
The American Journal of Medicine 1972
Drugs Affecting Therapy with Anticoagulants
J Eipe
Medical Clinics of North America 1972
Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man
, W Eiden, M Schettle, M Hahn, E Walter, E Weber
European Journal of Clinical Pharmacology 1972
In vivo andin vitro availability of commercial warfarin tablets
JG Wagner, PG Welling, KP Lee, JE Walker
Journal of Pharmaceutical Sciences 1971
Drug Interactions with Coumarin Anticoagulants
J Koch-Weser, EM Sellers
New England Journal of Medicine 1971
Comparison of plasma concentrations of warfarin measured by both simple extraction and TLC methods
PG Welling, KP Lee, U Khanna, JG Wagner
Journal of Pharmaceutical Sciences 1970
The Second Reported Kindred with Hereditary Resistance to Oral Anticoagulant Drugs
RA O'Reilly
New England Journal of Medicine 1970
Warfarin Therapy
D Deykin
New England Journal of Medicine 1970
Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin
RA O'Reilly
Journal of Clinical Investigation 1969
Comparative pharmacokinetics of coumarin anticoagulants V: Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man
R Nagashima, G Levy
Journal of Pharmaceutical Sciences 1969
Essays in Toxicology
RP Smith
Essays in Toxicology 1969
Studies on Coumarin Anticoagulant Drugs
RA O'Reilly, JI Ohms, CH Motley
The Journal of biological chemistry 1969
VARIATIONS IN METABOLISM OF COUMARIN ANTICOAGULANT DRUGS
HM Solomon
Annals of the New York Academy of Sciences 1968
HEREDITARY RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS IN MAN AND RAT
RA O'Reilly, JG Pool, PM Aggeler†
Annals of the New York Academy of Sciences 1968
Comparative pharmacokinetics of coumarin anticoagulants I. Unusual interaction of bishydroxycoumarin with plasma proteins—development of a new assay
R Nagashima, G Levy, E Nelson
Journal of Pharmaceutical Sciences 1968
COUMARIN ANTICOAGULANT REQUIREMENT IN RELATION TO SERUM CHOLESTEROL AND TRIGLYCERIDE LEVEL
K Pyörälä, EA Nikkilä, P Vuopio, G Myllylä
Acta Medica Scandinavica 1968
Stabilization of Anticoagulant Therapy By Simultaneous Coumarin and Vitamin k aDministration
JA Udall
Angiology 1968
Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose
RA O'reilly, PM Aggeler
Circulation 1968
Studies on the Coumarin Anticoagulant Drugs: Interaction of Human Plasma Albumin and Warfarin Sodium*
RA O'Reilly
Journal of Clinical Investigation 1967
Safe per-operative anticoagulation
J Wieberdink
Thorax 1967
Warfarin resistance
RJ Lewis, M Spivack, TH Spaet
The American Journal of Medicine 1967
Potentiation of Anticoagulant Effect of Warfarin by Phenylbutazone
PM Aggeler, RA O'Reilly, L Leong, PE Kowitz
New England Journal of Medicine 1967
Physicochemical and physiologic factors affecting the absorption of warfarin in man
RA O'reilly, E Nelson, G Levy
Journal of Pharmaceutical Sciences 1966
Anticoagulant Therapy in Coronary Artery Disease
S Wessler, LW Gaston
Circulation 1966
The Effect of Dicumarol, Diphacinone and Pivalyl Upon Blood Prothrombin Time of Chicks
OW Charles, BC Dilworth, RD Bushong, EJ Day
Poultry science 1966
Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques
G Woolfe, L Decsi, H Uehleke, S Archer, LS Harris, MW Whitehouse, JA Montgomery, E Jucker
1965
PHENINDIONE SENSITIVITY
A Hollman, HO Wong
British medical journal 1964
Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant Drugs: The First Reported Kindred
RA O'Reilly, PM Aggeler, MS Hoag, LS Leong, ML Kropatkin
New England Journal of Medicine 1964

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Posted by 1 X users
38 readers on Mendeley
See more details